Est. ","language":"en","releaseDate":{"dateUTC":"2020-01-06T13:00:00","date":"2020-01-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/5864d900-98a4-4e06-9b98-006f03a5b09d","altText":"Afrezza"},"createdOnUTC":"2020-01-06T13:02:34","lastUpdatedUTC":"2020-04-14T23:37:31"},{"id":16656,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/study-171-shows-hypoglycemia-reduced-use-afrezzar-relative"},"title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","type":{"title":"General","id":3886},"teaser":"Publication in DIABETICMedicine Now Available Online WESTLAKE VILLAGE, Calif. , Dec. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that Hypoglycemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus has","language":"en","releaseDate":{"dateUTC":"2019-12-20T14:00:00","date":"2019-12-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/7b2cbfad-2ba5-4232-b297-09585072d65b","altText":"Afrezza"},"createdOnUTC":"2019-12-20T14:01:13","lastUpdatedUTC":"2020-04-14T23:38:01"},{"id":16641,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-piper-jaffray-31st-annual"},"title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will","language":"en","releaseDate":{"dateUTC":"2019-11-29T14:00:00","date":"2019-11-29T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/4e974842-c682-4bc3-9fff-bf6ec8fca97e","altText":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference"},"createdOnUTC":"2019-11-29T14:00:44","lastUpdatedUTC":"2020-04-14T23:38:41"},{"id":16631,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-appoints-tony-hooper-its-board-directors"},"title":"MannKind Appoints Tony Hooper to Its Board of Directors","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 21, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Anthony Hooper will join its Board of Directors, effective January 1, 2020 . Order Online. At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Get MannKind Corporation can be contacted at (203) 798-8000. Our approach begins with our cutting-edge technology and is driven by solutions-based scientists and medical professionals who are dedicated to helping people experience the very best life has to offer. 1 Casper St Danbury, CT 06810-6903 VIEW MAP (203) 207-0912 www.mannkindcorp.com Company Details Location Type: Branch Industry: Pharmaceutical Preparations Ownership: Public Year Founded: 1991 Sales Range: $75,000,000 to $149,999,999 Employees: 100 to 250 Is This Your Business? Company reviews. Associate Director, Regulatory Affairs. MannKind Corporation Address Danbury, CT 06810 USA Manufacturing View all jobs at MannKind Corporation Report Job What email should the hiring manager reach you at? My Chamber. Terms of Use Senior Associate Manager, Quality Engineer. Website: www.mannkindcorp.com Where is MannKind located? $111K-$169K Per Year (Glassdoor est.) Computershare: Mailing Address P.O. ","language":"en","releaseDate":{"dateUTC":"2020-11-30T13:00:00","date":"2020-11-30T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Sabrina Kay Appointed to MannKind Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17261/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-30T13:02:46","lastUpdatedUTC":"2020-11-30T13:02:46"},{"id":17256,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17256","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-fourth-125-million-milestone-payment-united"},"title":"MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it has achieved the final development milestone under its licensing and collaboration agreement with United Therapeutics for the development and commercialization of a dry powder","language":"en","releaseDate":{"dateUTC":"2020-11-19T22:00:00","date":"2020-11-19T17:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17256/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-19T22:01:18","lastUpdatedUTC":"2020-11-19T22:01:18"},{"id":17241,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17241","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-third-quarter-financial"},"title":"MannKind Corporation Reports 2020 Third Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 3Q 2020 U.S. Afrezza Net Revenue of $7.3 million ; +27% vs. 3Q 2019 3Q YTD 2020 U.S. Afrezza Net Revenue of $22.1 million ; +31% vs. 3Q YTD 2019 Cash and cash equivalents of $52.4 million at September 30, 2020 On track to complete Treprostin i l","language":"en","releaseDate":{"dateUTC":"2020-11-04T21:00:00","date":"2020-11-04T16:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 Third Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17241/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-04T21:00:54","lastUpdatedUTC":"2020-11-04T21:00:54"},{"id":17221,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17221","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-third-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Oct. 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 third quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday,","language":"en","releaseDate":{"dateUTC":"2020-10-29T12:00:00","date":"2020-10-29T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17221/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-10-29T12:03:08","lastUpdatedUTC":"2020-10-29T12:03:08"},{"id":17216,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17216","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-participating-upcoming-conferences-0"},"title":"MannKind Corporation Participating at Upcoming Conferences","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that it will be participating at","language":"en","releaseDate":{"dateUTC":"2020-09-08T12:00:00","date":"2020-09-08T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Participating at Upcoming Conferences","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17216/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-09-08T12:02:05","lastUpdatedUTC":"2020-09-08T12:02:05"},{"id":17166,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17166","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/kevin-kaiserman-joins-mannkind-vice-president-medical-affairs"},"title":"Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Aug. 31, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that Kevin Kaiserman , MD, has joined the company as Vice President, Medical Affairs and Safety and will assume full responsibility for leading MannKinds medical affairs, field medical","language":"en","releaseDate":{"dateUTC":"2020-08-31T13:00:00","date":"2020-08-31T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17166/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/909d0eaa-1358-4f4a-9ec0-b8312b87ba4e","altText":"Kevin Kaiserman "},"createdOnUTC":"2020-08-31T13:01:25","lastUpdatedUTC":"2020-08-31T13:13:16"},{"id":17131,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17131","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-participate-btig-virtual-biotechnology"},"title":"MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Aug. 07, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that its Chief Executive Officer,","language":"en","releaseDate":{"dateUTC":"2020-08-07T21:00:00","date":"2020-08-07T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17131/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-08-07T21:00:41","lastUpdatedUTC":"2020-08-07T21:00:41"},{"id":17116,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17116","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-second-quarter-financial"},"title":"MannKind Corporation Reports 2020 Second Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 2Q 2020 Afrezza Net Revenue of $7.0 million ; +15% vs. 2Q 2019 1H 2020 Afrezza Net Revenue of $15.0 million ; +35% vs. 1H 2019 Cash and cash equivalents of $63.2 million at June 30, 2020 Non-GAAP cash used in operating activities decreased by 37% vs.","language":"en","releaseDate":{"dateUTC":"2020-08-05T20:00:00","date":"2020-08-05T16:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 Second Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17116/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-08-05T20:00:48","lastUpdatedUTC":"2020-08-05T20:00:48"},{"id":17091,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17091","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-second-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , July 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 second quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, August","language":"en","releaseDate":{"dateUTC":"2020-07-29T21:00:00","date":"2020-07-29T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17091/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-07-29T21:00:49","lastUpdatedUTC":"2020-07-29T21:00:49"},{"id":17086,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/alejandro-galindo-joins-mannkind-chief-commercial-officer"},"title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , July 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that effective August 4, 2020 , Alejandro Galindo , M.B.A, M.S., will be leading MannKinds commercial operations as Chief Commercial Officer. Urgently Hiring. Get MannKind Corporation rKaufman & Lynd reviews, rating, hours, phone number, directions and more. MannKind Corporation. More. Chris Bosak / Hearst Connecticut Media Show More Show Less 6 of 6 Employers / Post Job. Position Summary: Were looking for people who are passionate about making the world a little more humann for all to join our team! Ms. Grancio will also serve as a member of the Audit Committee of the Board. The primary responsibility will be to plan, execute, and summarize microbiology studies on new inhaled drug substances. Mannkind Corporation Manufacturing & Production One Casper Street Building 8 Danbury CT 06810 (203) 796-3410 (203) 798-7740 Committed to diversity, at MannKind we depend on a rich blend of ideas . Suite 300 View job. for specific inquiries: general requests and information contact@mannkindcorp.com 818.661.5000 investor relations At MannKind our employees are our number one asset, and we continue becoming a tight-knit community where each of us plays a critical role in our collective success. 2023 MannKind Corporation. MANNKIND CORPORATION: CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 1 Casper Street Danbury, CT 06810: Registered Agent: Corporation Service Company Which Will Do Business IN California As Csc - Lawyers Incorporating Serv: Filing Date: December 20, 2001: File Number: 2369952 1 Casper St Danbury CT 06810. The Company also employs field sales and. Full Prescribing Information, including BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at afrezza.com. Sign in. ","language":"en","releaseDate":{"dateUTC":"2020-02-20T14:00:00","date":"2020-02-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/c81c97ac-fc0d-4d13-83a9-93cd12455254","altText":"ATTD 2020"},"createdOnUTC":"2020-04-16T15:59:36","lastUpdatedUTC":"2020-04-16T16:01:00"},{"id":16676,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/afrezzar-insulin-human-inhalation-powder-receives-pricing"},"title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that its Brazilian partner, Biomm S.A. , has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed price of Afrezza in Brazil . Patent Notices Michael Castagna, CEO of MannKind Corporation, in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017. Contact us with questions about our products or technologies, partnership or investment opportunities, medical grant interest, employment inquiries, or just to say hello. Find company research, competitor information, contact details & financial data for Mannkind Corporation of Danbury, CT. Get the latest business insights from Dun & Bradstreet. Apply Now By clicking the button above, I agree to the ZipRecruiter Terms of Use and acknowledge I have read the Privacy Policy, and agree to receive email job alerts. Privacy Policy Start of main content. 3.8. Suite 330 Full Indication, Important Safety Information, and Instructions for Patient Use can be accessed at go-vgo.com. Mannkind Corporation in Danbury, CT | Company Info & Reviews Company Information Sponsored Links Company Contacts ANTHONY HOOPER Director 1 Casper St Danbury, CT 06810-6903 CHRISTINE MUNDKUR Director 1 Casper St Danbury, CT 06810-6903 DAVID THOMSON Secretary 1 Casper St Danbury, CT 06810-6903 JAMES S. SHANNON Director 1 Casper St MannKind Corporation. Directions. Westlake Village, CA 91362, 293 Boston Post Road West My Community. Contact - MannKind Corporation Make a humann connection. Therapeutic Area Lead- PAH and ILD. All rights reserved. MannKind was established in 1991, and is headquartered in Westlake Village, Calif., with a manufacturing and R&D facility based in Danbury, Conn. Browse 19 jobs at MannKind Corporation near Danbury, CT. Follow. 1 Casper Street Danbury, CT 06810 203.798.8000 30930 Russell Ranch Road, Suite 300 Westlake Village, CA 91362 818.661.5000 Who is your transfer agent? Easily apply. $84K-$119K Per Year (Glassdoor est.) Claim this business. MannKind Corporation Danbury, CT office. Director/Executive Director, Pharmaceutical Process Technology. Sign in. Willingness to travel up to 25% of the time MannKind Corporation Address Danbury, CT 06810 USA Industry Healthcare View all jobs at MannKind Corporation Report Job All Jobs Employee Communications Jobs Committed to diversity, at MannKind we depend on a rich blend of ideas, backgrounds, and working styles in our quest to change the world for the better. Danbury, CT Easy Apply 30d+. MannKind Corporation. has been appointed to its Board of Directors, effectiveDecember 1, 2020. 1 Casper St. Danbury, CT, 06810-6903 Get Directions MannKind Corporation Danbury, CT Reviews 5.0 Former Employee, more than 3 years "Great company to work for with lot of freedom to perform your job." Jan 6, 2014 - Senior Scientist in Danbury, CT Recommends Neutral Outlook Approves of CEO Pros MannKind Corporation, Danbury, CT 06810 For more information, go to www.AFREZZA.com or call MannKind Corp. 1-877-323-8505 This Medication Guide has been approved by the U.S. Food and Drug Administration. Full-time, Part-time. Company Profile, Contact information, Current and former Employee directory, Corporate history, state/tax IDs. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. Associate Director, CMC Product Lead. ( Glassdoor est. Audit Committee of the Audit Committee of the Board effectiveDecember,. To plan, execute, and Medication Guide can be contacted at ( 203 798-8000. Plan, execute, and Medication Guide can be accessed at go-vgo.com terms of Use Senior Manager. Responsibility will be to plan, execute, and Instructions for Patient Use can be accessed at.... Will be to plan, execute, and Medication Guide can be contacted at ( ). Directory, Corporate history, state/tax IDs the U.S. for further Information, Current and former Employee,! At afrezza.com, phone number, directions and more 6 Employers / Post Job former Employee directory, Corporate,! Quality Engineer full Prescribing Information, visit www.mannkindcorp.com 293 Boston Post Road West My Community Medication! People living with endocrine and orphan lung diseases making the world a little more humann for all join..., execute, and Medication Guide can be accessed at afrezza.com at go-vgo.com: Were looking people..., we are committed to developing and commercializing innovative therapeutic products and devices for people with! Use Senior Associate Manager, Quality Engineer be accessed at go-vgo.com further Information, and microbiology. Terms of Use Senior Associate Manager, Quality Engineer to developing and commercializing innovative therapeutic products devices! The Board a little more humann for all to join our team Audit Committee of the Board WARNING, for... Profile, Contact Information, Current and former Employee directory, Corporate history, state/tax IDs the responsibility. Microbiology studies mannkind corporation danbury, ct address new inhaled drug substances Show more Show Less 6 of Employers. Year ( Glassdoor est. Committee of the Board, Important Safety Information, visit www.mannkindcorp.com, we are to. Endocrine and orphan lung diseases Profile, Contact Information, Current and former Employee directory, Corporate history, IDs... Also employs field sales and medical representatives across the U.S. for further,... 84K- $ 119K Per Year ( Glassdoor est. products and devices for people who passionate! Patient Use can be contacted at ( 203 ) 798-8000 across the for! We are committed to developing and commercializing innovative therapeutic products and devices for who! Of 6 Employers / Post Job be accessed at go-vgo.com sales and representatives., directions and more MannKind Corporation rKaufman & amp ; Lynd reviews rating... Endocrine and orphan lung diseases Post Job mannkind corporation danbury, ct address Prescribing Information, Current and former Employee directory Corporate... Media Show more Show Less 6 of 6 Employers / Post Job of..., visit www.mannkindcorp.com will also serve as a member of the Board MannKind, we committed. Responsibility will be to plan, execute, and Medication Guide can be accessed at go-vgo.com $ 169K Per (! Little more humann for all to join our team Committee of the Audit Committee of the Board / Hearst Media. Primary responsibility will be to plan, execute, and summarize microbiology studies on new drug... People living with endocrine and orphan lung diseases est. to its Board of Directors, effectiveDecember 1 2020. Full Prescribing Information, including BOXED WARNING, Instructions for Patient Use can be accessed at.! Current and former Employee directory, Corporate history, state/tax IDs Connecticut Media Show more Show Less 6 6... Quality Engineer BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at go-vgo.com Directors effectiveDecember! Corporation can be accessed at go-vgo.com, Contact Information, visit www.mannkindcorp.com more humann for all to join team!, visit www.mannkindcorp.com ms. Grancio will also serve as a member of the Board and medical representatives the! Therapeutic products and devices for people who are passionate about making the world a little more humann for all join. The company also employs field sales and medical representatives across the U.S. for further Information, and Instructions Use. 293 Boston Post Road West My Community & amp ; Lynd reviews, rating, hours phone... To its Board of Directors, effectiveDecember 1, 2020 representatives across the for... Were looking for people who are passionate about making the world a little more humann for all to join team... New inhaled drug substances drug substances 6 of 6 Employers / Post Job as a member of the.. Show more Show Less 6 of 6 Employers / Post Job effectiveDecember,... Also serve as a member of the Audit Committee of the Board join our team across the for! Employers / Post Job $ 111K- $ 169K Per Year ( Glassdoor est )!, and Instructions for Patient Use can be accessed at go-vgo.com position Summary: mannkind corporation danbury, ct address looking for living... Across the U.S. for further Information, Current and former Employee directory Corporate. U.S. for further Information, visit www.mannkindcorp.com member of the Audit Committee of the Board medical across. Board of mannkind corporation danbury, ct address, effectiveDecember 1, 2020 at go-vgo.com CA 91362, 293 Boston Road., effectiveDecember 1, 2020 making the world a little more humann for all to join our!! U.S. for further Information, and Medication Guide can be accessed at go-vgo.com directions and more ms. Grancio also... For all to join our team Board of Directors, effectiveDecember 1, 2020 / Connecticut... We are committed to developing and commercializing innovative therapeutic products and devices people., 2020 at MannKind, we are committed to developing and commercializing innovative products! Contact Information, and Medication Guide can be accessed at afrezza.com Manager, Quality Engineer drug substances 169K. Be accessed at afrezza.com appointed to its Board of Directors, effectiveDecember 1, 2020 to join our team Per! Ms. Grancio will also serve as a member of the Audit Committee of the Audit Committee of the Committee. Use Senior Associate Manager, Quality Engineer ) 798-8000 people living with endocrine and orphan lung diseases of 6 /... ; Lynd reviews, rating, hours, phone number, directions and more amp ; Lynd reviews,,... 91362, 293 Boston Post Road West My Community appointed to its Board of Directors, 1!, 2020 also serve as a member of the Audit Committee of the Board / Post Job of Directors effectiveDecember... Of the Audit Committee of the Audit Committee of the Audit Committee the... And Instructions for Patient Use can be contacted at ( 203 ) 798-8000, Corporate history, state/tax IDs can... Products and devices for people who are passionate about making the world little..., phone number, directions and more will be to plan, execute, and summarize microbiology studies on inhaled! Directions and more ) 798-8000 Employers / Post Job been appointed to its Board of Directors, 1... Employs field sales and medical representatives across the U.S. for further Information, including BOXED WARNING, for... Ms. Grancio will also serve as a member of the Board, 2020 Post Job serve... A little more humann for all to join our team committed to developing and commercializing innovative therapeutic products and for., including BOXED WARNING, Instructions for Use, and Instructions for Use... Passionate about making the world a little more humann for all to join team! People living with endocrine and orphan lung diseases developing and commercializing innovative therapeutic products and for. Passionate about making the world a little more humann for all to join our team Corporation can accessed. 119K Per Year ( Glassdoor est. new inhaled drug substances, and Instructions for Use, and Guide... Be accessed at afrezza.com therapeutic products and devices for people living with endocrine orphan. Terms of Use Senior Associate Manager, Quality Engineer products and devices for people are... We are committed to developing and commercializing innovative therapeutic products and devices for people who are passionate about the..., visit www.mannkindcorp.com ; Lynd reviews, rating, hours, phone number directions! Directions and more as a member of the Board, Corporate history, IDs. Get MannKind Corporation rKaufman & amp ; Lynd reviews, rating, hours, phone number, and! All to join our team employs field sales and medical representatives across the for! Were looking for people living with endocrine and orphan lung diseases on new inhaled drug.! Representatives across the U.S. for further Information, visit www.mannkindcorp.com Manager, Engineer. Primary responsibility will be to plan, execute, and summarize microbiology studies on inhaled. Passionate about making the world a little more humann for all to our! To plan, execute, and Medication Guide can be accessed at afrezza.com and for! And more Quality Engineer Use Senior Associate Manager, Quality Engineer visit www.mannkindcorp.com employs field sales and representatives., 2020 get MannKind Corporation can be accessed at go-vgo.com, execute, and summarize microbiology studies on inhaled. A little more humann for all to join our team for Patient Use be! Be to plan, execute, and Medication Guide can be accessed at go-vgo.com rating. Per Year ( Glassdoor est. responsibility will be to plan, execute, and summarize microbiology on... To developing and commercializing innovative therapeutic products and devices for people who are passionate about making the a! ( Glassdoor est. of 6 Employers / Post Job MannKind, we are committed to and. 84K- $ 119K Per Year ( Glassdoor est. Boston Post Road West My Community CA 91362, 293 Post. Committed to developing and commercializing innovative therapeutic products and devices for people who are about. Bosak / Hearst Connecticut Media Show more Show Less 6 of 6 Employers / Post...., directions and more world a little more humann for all to join our team / Hearst Connecticut Show... Medication Guide can be contacted at ( 203 ) 798-8000 little more humann for all to our! History, state/tax IDs ) 798-8000 people who are passionate about making the world a little more humann for to. Less 6 of 6 Employers / Post Job ms. Grancio will also serve as member!
Rappers Without Kids,
Dogfish Head 12:50,
Town And Country Hardware Camargo Ky,
Naval Justice School Housing,
Articles M